Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Antivirus immune activity in multiple sclerosis correlates with MRI activity.

Latham LB, Lee MJ, Lincoln JA, Ji N, Forsthuber TG, Lindsey JW.

Acta Neurol Scand. 2016 Jan;133(1):17-24. doi: 10.1111/ane.12417. Epub 2015 May 4.

PMID:
25939660
2.

Decreased T cell reactivity to Epstein-Barr virus infected lymphoblastoid cell lines in multiple sclerosis.

Pender MP, Csurhes PA, Lenarczyk A, Pfluger CM, Burrows SR.

J Neurol Neurosurg Psychiatry. 2009 May;80(5):498-505. doi: 10.1136/jnnp.2008.161018. Epub 2008 Nov 17.

3.

T-cell response against varicella-zoster virus in fingolimod-treated MS patients.

Ricklin ME, Lorscheider J, Waschbisch A, Paroz C, Mehta SK, Pierson DL, Kuhle J, Fischer-Barnicol B, Sprenger T, Lindberg RL, Kappos L, Derfuss T.

Neurology. 2013 Jul 9;81(2):174-81. doi: 10.1212/WNL.0b013e31829a3311. Epub 2013 May 22.

PMID:
23700335
4.

Epstein-Barr virus and multiple sclerosis: cellular immune response and cross-reactivity.

Lindsey JW, Hatfield LM.

J Neuroimmunol. 2010 Dec 15;229(1-2):238-42. doi: 10.1016/j.jneuroim.2010.08.009. Epub 2010 Sep 9.

PMID:
20826010
5.

An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study.

Sundström P, Juto P, Wadell G, Hallmans G, Svenningsson A, Nyström L, Dillner J, Forsgren L.

Neurology. 2004 Jun 22;62(12):2277-82.

PMID:
15210894
6.

EBV & HHV6 reactivation is infrequent and not associated with MS clinical course.

Simpson S Jr, Taylor B, Burrows J, Burrows S, Dwyer DE, Taylor J, Ponsonby AL, Blizzard L, Dwyer T, Pittas F, van der Mei I.

Acta Neurol Scand. 2014 Nov;130(5):328-37. doi: 10.1111/ane.12268. Epub 2014 Jun 3.

PMID:
24893674
7.

Increased CD8+ T cell response to Epstein-Barr virus lytic antigens in the active phase of multiple sclerosis.

Angelini DF, Serafini B, Piras E, Severa M, Coccia EM, Rosicarelli B, Ruggieri S, Gasperini C, Buttari F, Centonze D, Mechelli R, Salvetti M, Borsellino G, Aloisi F, Battistini L.

PLoS Pathog. 2013;9(4):e1003220. doi: 10.1371/journal.ppat.1003220. Epub 2013 Apr 11.

8.

Epstein-Barr virus antibodies in serum and DNA load in saliva are not associated with radiological or clinical disease activity in patients with early multiple sclerosis.

Gieß RM, Pfuhl C, Behrens JR, Rasche L, Freitag E, Khalighy N, Otto C, Wuerfel J, Brandt AU, Hofmann J, Eberspächer B, Bellmann-Strobl J, Paul F, Ruprecht K.

PLoS One. 2017 Apr 7;12(4):e0175279. doi: 10.1371/journal.pone.0175279. eCollection 2017.

9.

Epstein-Barr virus is associated with grey matter atrophy in multiple sclerosis.

Zivadinov R, Zorzon M, Weinstock-Guttman B, Serafin M, Bosco A, Bratina A, Maggiore C, Grop A, Tommasi MA, Srinivasaraghavan B, Ramanathan M.

J Neurol Neurosurg Psychiatry. 2009 Jun;80(6):620-5. doi: 10.1136/jnnp.2008.154906. Epub 2009 Jan 23.

PMID:
19168469
10.

Quantitative PCR for Epstein-Barr virus DNA and RNA in multiple sclerosis.

Lindsey JW, Hatfield LM, Crawford MP, Patel S.

Mult Scler. 2009 Feb;15(2):153-8. doi: 10.1177/1352458508097920. Epub 2008 Oct 9.

PMID:
18845656
11.

Longitudinal analysis of frequency and reactivity of Epstein-Barr virus-specific T lymphocytes and their association with intermittent viral reactivation.

Vogl BA, Fagin U, Nerbas L, Schlenke P, Lamprecht P, Jabs WJ.

J Med Virol. 2012 Jan;84(1):119-31. doi: 10.1002/jmv.22258.

PMID:
22095540
12.

Higher incidence of Epstein-Barr virus-induced lymphocyte transformation in multiple sclerosis.

Tørring C, Andreasen C, Gehr N, Bjerg L, Petersen T, Höllsberg P.

Acta Neurol Scand. 2014 Aug;130(2):90-6. doi: 10.1111/ane.12249. Epub 2014 Mar 31.

PMID:
24684660
13.

Combination of Epstein-Barr virus nuclear antigen 1, 3 and lytic antigen BZLF1 peptide pools allows fast and efficient stimulation of Epstein-Barr virus-specific T cells for adoptive immunotherapy.

Wang Y, Aïssi-Rothe L, Virion JM, De Carvalho Bittencourt M, Ulas N, Audonnet S, Salmon A, Clement L, Venard V, Jeulin H, Stoltz JF, Decot V, Bensoussan D.

Cytotherapy. 2014 Jan;16(1):122-34. doi: 10.1016/j.jcyt.2013.07.008. Epub 2013 Oct 1.

PMID:
24094498
14.

The participation of varicella zoster virus in relapses of multiple sclerosis.

Sotelo J, Ordoñez G, Pineda B, Flores J.

Clin Neurol Neurosurg. 2014 Apr;119:44-8. doi: 10.1016/j.clineuro.2013.12.020. Epub 2014 Jan 10.

PMID:
24635924
15.

Intrathecal antibody production against Epstein-Barr and other neurotropic viruses in pediatric and adult onset multiple sclerosis.

Pohl D, Rostasy K, Jacobi C, Lange P, Nau R, Krone B, Hanefeld F.

J Neurol. 2010 Feb;257(2):212-6. doi: 10.1007/s00415-009-5296-y. Epub 2009 Aug 28.

16.

Epstein-Barr virus in pediatric multiple sclerosis.

Alotaibi S, Kennedy J, Tellier R, Stephens D, Banwell B.

JAMA. 2004 Apr 21;291(15):1875-9.

PMID:
15100207
17.

Evaluation of reactive Epstein-Barr Virus (EBV) in Iranian patient with different subtypes of multiple sclerosis (MS).

Ramroodi N, Niazi AA, Sanadgol N, Ganjali Z, Sarabandi V.

Braz J Infect Dis. 2013 Mar-Apr;17(2):156-63. doi: 10.1016/j.bjid.2012.09.008. Epub 2013 Mar 5.

18.

Immune and Epstein-Barr virus gene expression in cerebrospinal fluid and peripheral blood mononuclear cells from patients with relapsing-remitting multiple sclerosis.

Veroni C, Marnetto F, Granieri L, Bertolotto A, Ballerini C, Repice AM, Schirru L, Coghe G, Cocco E, Anastasiadou E, Puopolo M, Aloisi F.

J Neuroinflammation. 2015 Jul 14;12:132. doi: 10.1186/s12974-015-0353-1.

19.

Association of innate immune activation with latent Epstein-Barr virus in active MS lesions.

Tzartos JS, Khan G, Vossenkamper A, Cruz-Sadaba M, Lonardi S, Sefia E, Meager A, Elia A, Middeldorp JM, Clemens M, Farrell PJ, Giovannoni G, Meier UC.

Neurology. 2012 Jan 3;78(1):15-23. doi: 10.1212/WNL.0b013e31823ed057. Epub 2011 Dec 7.

PMID:
22156987
20.

Addition of varicella zoster virus-specific T cells to cytomegalovirus, Epstein-Barr virus and adenovirus tri-specific T cells as adoptive immunotherapy in patients undergoing allogeneic hematopoietic stem cell transplantation.

Ma CK, Blyth E, Clancy L, Simms R, Burgess J, Brown R, Deo S, Micklethwaite KP, Gottlieb DJ.

Cytotherapy. 2015 Oct;17(10):1406-20. doi: 10.1016/j.jcyt.2015.07.005.

PMID:
26349000

Supplemental Content

Support Center